For research use only. Not for therapeutic Use.
Neutral sphingomyelinases mediate the release of ceramide from sphingomyelin in cellular membranes and can be activated by certain stresses. Ceramide can act as a signaling molecule in its own right, or it can be further processed to generate sphingosine (and sphingosine-<wbr></wbr>1-<wbr></wbr>phosphate). GW 4869 is a cell-<wbr></wbr>permeable, non-<wbr></wbr>competitive inhibitor of neutral sphingomyelinases (IC<sub>50</sub> = 1 μM), but does not affect acid sphingomyelinase activity. It inhibits TNF-<wbr></wbr>α-<wbr></wbr>mediated sphingomyelin hydrolysis (100% inhibition at 20 μM) and TNF-<wbr></wbr>α-<wbr></wbr>induced cell death in MCF-7 cells without interfering with activation of NF-<wbr></wbr>κB or glutathione depletion in response to TNF. GW 4869 also reduces the inhibitory effect of oxidized phospholipid products on lipopolysaccharides-<wbr></wbr>mediated induction of interleukin-<wbr></wbr>8 in human aortic endothelial cells and prevents hypoxia-<wbr></wbr>induced pulmonary vasoconstriction in rats <em>in vivo</em>.
Catalog Number | M024107 |
CAS Number | 6823-69-4 |
Synonyms | N-SMase Inhibitor;2-PropenaMide, 3,3/’-(1,4-phenylene)bis[N-[4-(4,5-dihydro-1H-iMidazol-2-yl)phenyl]-, hydrochloride (1:2);4/’,4/’/’-Di-2-imidazolin-2-yl-p-benzenediacrylanilide dihydrochloride;GW 4869 (hydrochloride hydrate) |
Molecular Formula | C₃₀H₂₈N₆O₂ · 2HCl [xH₂O] |
Purity | ≥95% |
Target | Phospholipase |
Storage | -20°C |
InChI | InChI=1S/C30H28N6O2.2ClH/c37-27(35-25-11-7-23(8-12-25)29-31-17-18-32-29)15-5-21-1-2-22(4-3-21)6-16-28(38)36-26-13-9-24(10-14-26)30-33-19-20-34-30;;/h1-16H,17-20H2,(H,31,32)(H,33,34)(H,35,37)(H,36,38);2*1H/b15-5+,16-6+;; |
InChIKey | NSFKAZDTKIKLKT-CLEIDKRQSA-N |
SMILES | C1CN=C(N1)C2=CC=C(C=C2)NC(=O)C=CC3=CC=C(C=C3)C=CC(=O)NC4=CC=C(C=C4)C5= |